Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to $7.3 million.

  • Apyx Medical's Accumulated Expenses rose 72.69% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 72.69%. This contributed to the annual value of $7.8 million for FY2024, which is 1977.02% down from last year.
  • As of Q3 2025, Apyx Medical's Accumulated Expenses stood at $7.3 million, which was up 72.69% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Accumulated Expenses ranged from a high of $10.3 million in Q4 2021 and a low of $6.8 million during Q1 2025
  • Its 5-year average for Accumulated Expenses is $8.1 million, with a median of $7.9 million in 2023.
  • In the last 5 years, Apyx Medical's Accumulated Expenses soared by 4134.38% in 2021 and then plummeted by 1977.02% in 2024.
  • Over the past 5 years, Apyx Medical's Accumulated Expenses (Quarter) stood at $10.3 million in 2021, then decreased by 13.21% to $8.9 million in 2022, then grew by 8.21% to $9.7 million in 2023, then dropped by 19.77% to $7.8 million in 2024, then fell by 5.25% to $7.3 million in 2025.
  • Its Accumulated Expenses was $7.3 million in Q3 2025, compared to $7.3 million in Q2 2025 and $6.8 million in Q1 2025.